Development of a marker of estrogenic exposure in breast cancer patients

Adv Exp Med Biol. 1998:444:29-40. doi: 10.1007/978-1-4899-0089-0_4.

Authors

P Pazos¹, P Pérez, A Rivas, R Nieto, B Botella, J Crespo, F Olea-Serrano, M F Fernández, J Expósito, N Olea, V Pedraza

Affiliation

¹ Department of Radiology, University of Granada, Spain.

PMID: 10026931
DOI: 10.1007/978-1-4899-0089-0_4

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adipose Tissue / chemistry
Biomarkers / analysis*
Breast Neoplasms / chemically induced*
Breast Neoplasms / chemistry*
Breast Neoplasms / pathology
Cathepsin D / analysis
Cell Division / drug effects
Chromatography, Gas
Chromatography, High Pressure Liquid
Estradiol / pharmacology
Estrogens / analysis*
Female
Gas Chromatography-Mass Spectrometry
Humans
Receptors, Estrogen / analysis
Receptors, Progesterone / analysis
Tumor Cells, Cultured
Tumor Suppressor Protein p53 / analysis
Xenobiotics / analysis*

Substances

Biomarkers
Estrogens
Receptors, Estrogen
Receptors, Progesterone
Tumor Suppressor Protein p53
Xenobiotics
Estradiol
Cathepsin D